Literature DB >> 14441855

Recognition and management of drug-induced extra-pyramidal reactions and "paradoxical" behavioural reactions in psychiatry.

G J SARWER-FONER.   

Abstract

Keywords:  EXTRAPYRAMIDAL TRACTS/physiology; TRANQUILIZING AGENTS/toxicology

Mesh：

Substances：

Year:  1960        PMID： 14441855      PMCID： PMC1938588     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  10 in total

1.  Depressive states and drugs; a study of the use of imipramine tofranil in open psychiatric settings.

Authors:  G J SARWER-FONER; H GRAUER; J MACKAY; E K KORANYI
Journal:  Med Serv J Can       Date:  1959-06

2.  [Occurrence and interpretation of psychomotor parkinsonism in megaphen or largactil prolonged therapy].

Authors:  H J HAASE
Journal:  Nervenarzt       Date:  1954-12-20       Impact factor: 1.214

3.  The clinical investigation of pacatal in open psychiatric settings.

Authors:  G J SARWER-FONER; E K KORANYI
Journal:  Can Med Assoc J       Date:  1957-09-01       Impact factor: 8.262

4.  Psychoanalytic theories of activity-passivity conflicts and of the continuum of ego defenses; experimental verification, using reserpine and chlorpromazine.

Authors:  G J SARWER-FONER
Journal:  AMA Arch Neurol Psychiatry       Date:  1957-10

5.  [Hysterical states of medicinal origin].

Authors:  J DELAY; P DENIKER
Journal:  Can Psychiatr Assoc J       Date:  1958-07

6.  Pharmacotherapeutic evaluation and the psychiatric setting.

Authors:  M SABSHIN; J RAMOT
Journal:  AMA Arch Neurol Psychiatry       Date:  1956-04

7.  Use of reserpine in disturbed psychotic patients.

Authors:  J A BARSA; N S KLINE
Journal:  Am J Psychiatry       Date:  1956-03       Impact factor: 18.112

8.  The use of reserpine in an open psychiatric setting.

Authors:  G J SARWER-FONER; W OGLE
Journal:  Can Med Assoc J       Date:  1955-08-01       Impact factor: 8.262

9.  Depressive states and drugs. II. The study of phenelzine dihydrogen sulfate (nardil) in open psychiatric settings.

Authors:  G J SARWER-FONER; E K KORANYI; A MESZAROS; H GRAUER
Journal:  Can Med Assoc J       Date:  1959-12-15       Impact factor: 8.262

10.  Clinical investigation of trifluoperazine (stelazine) in open psychiatric settings.

Authors:  G J SARWER-FONER; E K KORANYI; J MACKAY; H GRAUER
Journal:  Can Med Assoc J       Date:  1959-11-01       Impact factor: 8.262
  10 in total
  4 in total

1.  Ethnicity and psychopharmacology.

Authors:  K M Lin; R E Poland; I M Lesser
Journal:  Cult Med Psychiatry       Date:  1986-06

2.  High dosage haloperidol therapy in chronic schizophrenic patients: a double-blind study of clinical response, side effects, serum haloperidol, and serum prolactin.

Authors:  N Bjørndal; M Bjerre; J Gerlach; P Kristjansen; G Magelund; I H Oestrich; J Waehrens
Journal:  Psychopharmacology (Berl)       Date:  1980-01       Impact factor: 4.530

3.  Pharmacological characterization of tardive dyskinesia.

Authors:  D E Casey; D Denney
Journal:  Psychopharmacology (Berl)       Date:  1977-08-31       Impact factor: 4.530

Review 4.  Acute dystonia induced by neuroleptic drugs.

Authors:  N M Rupniak; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.